Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 456-462

  Hamamoto, Junko ^a   Soejima, Kenzo ^a   Yoda, Satoshi ^a   Naoki, Katsuhiko ^a   Nakayama, Sohei ^a   Satomi, Ryosuke ^a   Terai, Hideki ^a   Ikemura, Shinnosuke ^a   Sato, Takashi ^a   Yasuda, Hiroyuki ^a   Hayashi, Yuichiro ^a   Sakamoto, Michiie ^a   Takebayashi, Toru ^a   Betsuyaku, Tomoko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Biomarker; Lung cancer; MicroRNA; Squamous cell carcinoma

Indexed keywords

MICRORNA; MICRORNA 196B; MICRORNA 205; MICRORNA 375; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879983640     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1517     Document Type: Article

References (26)

1. Herbst RS, Heymach JV and Lippman SM: Lung Cancer. N Engl J Med 359: 1367-1380, 2008.
2. Scagliotti GV, Parikh P, von Pawel J, et al: Phase III study comparing cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26: 3543-3551, 2008.
3. Ciuleanu T, Brodowicz T, Zielinski C, et al: Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 374: 1432-1440, 2009.
4. Gridelli C, Ardizzoni A, Douillard JY, et al: Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology. Lung Cancer 68: 319-331, 2010.
5. Rossi G, Pelosi G, Graziano P, Barbareschi M and Papotti M: A reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Int J Surg Pathol 17: 206-218, 2009.
6. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma. N Engl J Med 361: 947-957, 2009.
7. Kawada I, Soejima K, Watanabe H, et al: An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients. J Thorac Oncol 3: 1096-1103, 2008.
8. Sandler A, Gray R, Perry MC, et al: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355: 2542-2550, 2006.
9. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 4: 259-269, 2006.
10. Raponi D, Dossey L, Jatkoe T, et al: MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5783, 2009.
11. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 3: 189-198, 2006.
12. Colby TV, Noguchi M, Henschke C, et al: Adenocarcinoma. In: World Health Organization classification of tumours. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Muller-Hemelink HK and Harris CC (eds). IARC Press, Lyon, pp35-44, 2005.
13. Hammar SP, Brambilla C, Pugatch B, et al: Squamous cell carcinoma. In: World Health Organization classification of tumours. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Travis WD, Brambilla E, Muller-Hemelink HK and Harris CC, (eds). IARC Press, Lyon, pp26-30, 2005.
14. Lebanony D, Benjamin H, Gilad S, et al: Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030-2037, 2009.
15. Yu L, Todd NW, Xing L, et al: Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 127: 2870-2878, 2010.
16. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP and Westra WH: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16: 610-619, 2010.
17. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM and Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11: 50-54, 2010.
18. Popovic R, Riesbeck LE, Velu CS, et al: Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113: 3314-3322, 2009.
19. Schimanski CC, Berger M, Rahman F, et al: High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol 15: 2089-2096, 2009.
20. Wu H and Mo YY: Targeting miR-205 in breast cancer. Expert Opin Ther Targets 13: 1439-1448, 2009.
21. Childs G, Fazzari M, Kung G, et al: Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 17: 736-745, 2009.
22. Greene SB, Gunaratne PH, Hammond SM, and Rosen JM: A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci 123: 606-618, 2010.
23. Mathé EA, Nguyen GH, Bowman ED, et al: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200, 2009.
24. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D and van Obberghen E: miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57: 2708-2717, 2008.
25. Saji H, Tsuboi M, Matsubayashi J, et al: Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Anticancer Drugs 21: 89-83, 2010.
26. Kozuki T, Fujimoto N, Ueoka H, et al: Complexity in the treatment of pulmonary large cell neuroendocrinecarcinoma. J Cancer Res Clin Oncol 131: 147-51, 2005. of Japan of Japan